Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | ACHE | P22303 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CA5A | P35218 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 3/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | PDE2A | O00408 | 2/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MLYCD | O95822 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1538359 | 0.83 | TSHR (0.67) | TSHRACHETDP1CA1CA2 | |
| SCHEMBL11413652 | 0.78 | TSHR (0.60) | TSHRACHETDP1CA1CA2 | |
| SCHEMBL15745695 | 0.78 | TSHR (0.60) | TSHRACHETDP1CA1CA2 | |
| SCHEMBL2892242 | 0.78 | TSHR (0.60) | TSHRACHETDP1CA1CA2 | |
| SCHEMBL10843149 | 0.78 | TSHR (0.60) | TSHRACHETDP1CA1CA2 | |
| SCHEMBL1409623 | 0.78 | TSHR (0.60) | TSHRACHETDP1CA1CA2 | |
| SCHEMBL6049865 | 0.77 | TSHR (0.58) | TSHRACHETDP1CA1CA2 | |
| SCHEMBL13801220 | 0.77 | MEN1 (0.52) | TSHRNPC1RAB9APDE2ACYP19A1 | |
| Iodide SCHEMBL25233686 | 0.76 | TSHR (0.57) | TSHRACHETDP1CA1CA2 | |
| Hydrochloric Acid SCHEMBL16447038 | 0.76 | TSHR (0.57) | TSHRACHETDP1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3929217-A2 | SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES | Novartis AG (CH) | 2021-12-29 | — | — | EP | disclosed |